StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage0

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon May 01, 2024 10:46am

58 Views

Post# 36017209

RE:RE:Stage0

WillHey wrote: i didnt get to see the comment on my post. They worked fast to get it removed!

Here is a modified version:
"Yah nailed it. If szls ever resumes trading it will likely hit one half a cent before going belly up. Somebody needs to be held accountable for this outrageous non-product called Aristotle."

<< Previous

Bullboard Posts

Next >>

Canada Goose appoints first creative director